Unternehmen Aerie Pharmaceuticals, Inc.
Aktien
A1W7RL
US00771V1089
AERI
Pharmazeutika
Kurzporträt
Mitarbeiterzahl: 376
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 58 | 21.11.22 |
Andrew Allen
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01.03.22 | |
Chief Tech/Sci/R&D Officer | - | 03.02.20 | |
David Biddell
PRN | Corporate Officer/Principal | - | - |
Leon J. Atencia
PRN | Corporate Officer/Principal | - | 15.07.21 |
Evan Hockman
SAM | Sales & Marketing | - | - |
Wanda Francies
HRO | Human Resources Officer | - | - |
Kenji Aso
PRN | Corporate Officer/Principal | - | - |
Gerry McKenzie
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Ian Bell
BRD | Director/Board Member | 54 | 21.11.22 |
Chairman | 57 | 21.11.22 | |
Jonathan Balch
BRD | Director/Board Member | - | 21.11.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 49 417 407 | 49 245 119 ( 99,65 %) | 0 | 99,65 % |
Unternehmenskontakt
Aerie Pharmaceuticals, Inc.
6201 South Freeway
76134, Forth Worth
+919 237 5300
http://www.aeriepharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+33.46% | 701 Mrd. | |
+26.24% | 571 Mrd. | |
+0.93% | 381 Mrd. | |
+21.03% | 334 Mrd. | |
+17.51% | 319 Mrd. | |
+0.74% | 210 Mrd. | |
+2.95% | 210 Mrd. | |
-6.05% | 201 Mrd. | |
-3.61% | 157 Mrd. |